Clinical Trial Update: Safety and Efficacy of Activated Recombinant Human Factor VII in Patients Undergoing Orthotopic Liver Transplantation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of activated recombinant human coagulation factor VII in patients undergoing orthotopic liver transpla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Bleeding Disorders
• Postoperative Hemorrhage

Drugs mentioned

• NovoSeven (recombinant coagulation factor VIIa)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Acquired Bleeding Disorder, Bleeding During/Following Surgery | Phase 2 | Status: COMPLETED